The increased risk of Crohn’s disease observed in individuals with pathogenic nucleotide-binding oligomerization domain (NOD)−2 polymorphisms is believed to result from increased NF-κB binding activity in the colon and enhanced secretion of IL-1ß29. Here, NFKB1 is linked to Crohn disease.